1. Многоосевая классификация психических расстройств в детском и подростковом возрасте. Классификация психических и поведенческих расстройств у детей и подростков в соответствии с MKБ-10: учеб. пособие ⁄ науч. ред. русского текста А. H. Moxoвикoвa; пер. с англ. О. Ю. Донца. - 2-е изд., иcпp. - M.: Смысл; Издательский центр «Академия», 2008. -408 с.
2. Всемирная организация здравоохранения (ВОЗ). РАС (РАС) [Электронный ресурс]. URL: https://www.who. int/ru/news-rooщ/fact-sheets/detail/autism-spectrum-disorders (дата обращения 3.12.2019)
3. Hassan Μ. M., Mokhtar Η. Μ. О. Investigating autism etiology and heterogeneity by decision tree algorithm//Informatics in Medicine Unlocked. - 2019. - T. 16. - C. 100215.
4. De Rubers S., Buxbaum J. D. Genetics and genomics of autism spectrum disorder: embracing complexity//Human molecular genetics. - 2015. - T. 24. - №. Rl. - C. R24-R31.
5. Chaste P., Leboyer M. Autism risk factors: genes, environment, and gene-environment interactions //Dialogues in clinical neuroscience. - 2012. - T. 14. - №. 3. - C. 28
6. Richards C. et al. Prevalence of autism spectrum disorder phenomenology in genetic disorders: a systematic review and meta-analysis //The Lancet Psychiatry. - 2015. -T.2.- №. 10. - C. 909-916.
7. Ivanov H.Y. et al. Autism spectrum disorder-a complex genetic disorder //Folia medica. - 2015. -T.57.-№. 1.-C. 19-28.
8. Verhoeven W.M.A., Egger J.I.M., Feenstra I. Autism and genetic syndromes //Autism spectrum disorders: the role of genetics in diagnosis and treatment. Vienna: In Tech. - 2011. - C. 31-48.
9. Wen Z. et al. Identification of autism-related MECP2 mutations by whole-exome sequencing and functional validation//Molecular autism. - 2017. -T.8.- №. 1. - C. 43.
10. Baieli S. et al. Autism and phenylketonuria //Journal of autism and developmental disorders. -2003. - T. 33. - №. 2. - C. 201-204.
11. DiGuiseppi C. et al. Screening for autism spectrum disorders in children with Down syndrome: population prevalence and screening test characteristics //Journal of developmental and behavioral pediatrics: JDBP. - 2010. - T. 31. - №. 3. - C. 181.
12. Бoбылoвa Μ. Ю. и др. Синдром Φeлaн-MaкДepмид (del 22qlЗ и r (22)): обзор литературы и 2 случая //Русский журнал детской неврологии. - 2016. - №. 4.
13. Willemsen M. H. et al. Update onKleefstra syndrome //Molecular syndromology. - 2011. -T.2.-№.3-5.-C.202-212.
14. DΌnofrio В. M. et al. Paternal age at childbearing and offspring psychiatric and academic morbidity//JAMA psychiatry. - 2014. -T.71.- №. 4. - C. 432-438.
15. Hultman С. M. et al. Advancing paternal age and risk of autism: new evidence from a population-based study and a meta-analysis of epidemiological studies //Molecular psychiatry. -2011.-T. 16.-№. 12.-C. 1203.
16. Agrawal S. et al. Prevalence of autism spectrum disorder in preterm infants: a meta-analysis //Pediatrics. - 2018. - T. 142. - №. 3. - C. e20180134.
17. Cl·ıristensen J. et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism//Jama. - 2013. - T. 309. - №. 16. - C. 1696-1703.
18. Wan H. et al. Association of maternal diabetes with autism spectrum disorders in offspring: A systemic review and meta-analysis //Medicine. - 2018. - T. 97. - №. 2.
19. Taylor L. E., Swerdfeger A. L., Eslick G. D. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies //Vaccine. - 2014. - T. 32. - №. 29. - C. 3623-3629.
20. Jain A. et al. Autism occurrence by MMR vaccine status among US children with older siblings with and without autism//Jama. - 2015. - T. 313. - №. 15. - C. 1534-1540.
21. DeStefano F. Thimerosal-containing vaccines: evidence versus public apprehension //Expert opinion on drug safety. - 2009. -T.8.-№.l.-C.l-4.
22. Madsen К. M. et al. A Population-based study of measles, mumps, and rubella vaccination and autism//New England Journal of Medicine. - 2002. - № 19 (347). - C. 1477-1482.
23. Courchesne E. et al. Mapping early brain development in autism //Neuron. - 2007. - T. 56. - №. 2.-C.399-413.
24. Schmitz C., Rezaie P. The neuropathology of autism: where do we stand? //Neuropathology and applied neurobiology. - 2008. - T. 34. - №. 1. - C. 4-11.
25. Minshew Ν. J., Williams D. L. The new neurobiology of autism: cortex, connectivity, and neuronal organization //Archives of neurology. - 2007. - T. 64. - №. 7. - С. 945-950.
26. Perm Η. E. Neurobiological correlates of autism: a review of recent research //Child Neuropsychology. - 2006. - T. 12. - №. 1. - C. 57-79.
27. Dykens E. M., Sutcliffe J. S., Levitt P. Autism and 15qll-ql3 disorders: Behavioral, genetic, and pathophysiological issues //Mental retardation and developmental disabilities research reviews. - 2004. - T. 10. - №. 4. - C. 284-291
28. Baron-Cohen S., Leslie A. M., Frith U. Does the autistic child have a "theory of mind"? // Cognition. - 1985. - T. 21. - №. 1. - C. 37-46.
29. Happé F. G. E. An advanced test of theory of mind: Understanding of story characters" thoughts and feelings by able autistic, mentally handicapped, and normal children and adults //Journal of autism and Developmental disorders. - 1994. - T. 24. - №. 2. - C. 129-154.
30. Happé F., Frith U. The weak coherence account: detail-focused cognitive style in autism spectrum disorders //Journal of autism and developmental disorders. - 2006. - T. 36. - №. 1. - C. 5-25.
31. Hill E. L. Executive dysfunction in autism //Trends in cognitive sciences. - 2004. -T.8.- №. 1. -C. 26-32.
32. Meeting Report. Autism spectrum disorders & other developmental disorders: From raising awareness to building capacity (Geneva, 16-18 September 2013) //Geneva, Switzerland: WHO Document Production Services. - 2013. - C. 50
33. Baxter A. J. et al. The epidemiology and global burden of autism spectrum disorders //Psychological medicine. - 2015. - T. 45. - №. 3. - C. 601-613.
34. Maenner M. J. et al. Prevalence of autism spectrum disorder among children aged 8 years — Autism and developmental disabilities monitoring network, 11 sites, United States, 2016 // MMWR. Surveillance Summaries. - 2020. - № 4 (69). - C. 1-12.